Novo Nordisk A/S vs Solaredge Technologies Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Solaredge Technologies Inc trades at $50.3 (market cap $2.96B). The key difference: Novo Nordisk A/S is far larger — about 74.5× Solaredge Technologies Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Solaredge Technologies Inc pays none. Which is the better fit depends on your goals.
| NVO | SEDG | |
|---|---|---|
Market Cap | $220.53B | $2.96B |
Sector | Health | Technology |
52-Week High | $71.70 | $78.51 |
52-Week Low | $35.29 | $24.42 |
Enterprise Value | $239.49B | $2.89B |
Dividend Yield | 3.63% | — |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →